BBLG Live signaler | Maksimer profitt med Getagraph.com

SELG 121312 min ago

@ $4.66

Utstedt: 9 feb 2024 @ 21:44

Avkastning: -60.29%

Live Chart Being Loaded With Signals

Commentary (3 mai 2024 @ 22:00):

Stats
Dagens volum	24 904.00
Gjennomsnittsvolum	82 350.00
Markedsverdi	1.63M
EPS	$0 ( 2024-04-04 )
Neste inntjeningsdato	( $-7.60 ) 2024-05-20
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0500
ATR14	$0.0360 (2.00%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-17	Walsh Deina H	Buy	12 500	Employee Stock Option
2024-01-17	Frelick Jeff	Buy	25 000	Employee Stock Option
2024-01-08	Gagnon Robert E.	Buy	8	Non-Employee Stock Option
2024-01-08	Gagnon Robert E.	Buy	9	Non-Employee Stock Option
2024-01-08	Gagnon Robert E.	Sell	0	Common Stock

INSIDER POWER
33.00
Last 92 transactions
Buy: 61 072 197 \| Sell: 15 856 455

Volum Korrelasjon

Lang: 0.11 (neutral)

Kort: 0.30 (neutral)

Signal:(45.71) Neutral

Bone Biologics Korrelasjon

10 Mest positive korrelasjoner
TRKA	0.919
BIRD	0.904
EBTC	0.903
FLGT	0.902
MAXN	0.901
AFRM	0.896
RRGB	0.893
PWOD	0.891
RDFN	0.89
GP	0.889

10 Mest negative korrelasjoner
FINW	-0.896
ACGL	-0.883
ABST	-0.877
SLAB	-0.871
GXII	-0.871
MSAC	-0.87
EVBG	-0.868
PLMR	-0.865
RGCO	-0.864
KINS	-0.864

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Bone Biologics Korrelasjon - Valuta/Råvare

-0.16
( neutral )

-0.30
( neutral )

0.00
( neutral )

-0.31
( neutral )

0.65
( weak )

-0.02
( neutral )

Bone Biologics Økonomi

Annual	2023
Omsetning:	$0
Bruttogevinst:	$0 (0.00 %)
EPS:	$-34.01

FY	2023
Omsetning:	$0
Bruttogevinst:	$0 (0.00 %)
EPS:	$-34.01

FY	2022
Omsetning:	$0
Bruttogevinst:	$0 (0.00 %)
EPS:	$14.62

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-0.553

Financial Reports:

No articles found.

Bone Biologics

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. It is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. The company's platform technology has application in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. The company was founded in 2004 and is headquartered in Burlington, Massachusetts.